Institute for Molecular Medicine Finland
Dr. Vilja Pietiäinen’s research is focused on cancer precision medicine. The patient -derived cancer cells are isolated from tissues after the surgery, grown ex-vivo, and characterized with different omics technologies, including genomics, phenomics, and drug profiling. Dr. Pietiäinen develops also microscopic imaging –based solutions with her collaborators for phenotyping and drug profiling of patient –derived cells.
Cell biology Virology Cancer Microscopic imaging High throughput screening Drug testing RNAi screening